CN103993084B - For the amplification of androgen receptor gene full coding region abrupt climatic change and sequencing primer and test kit thereof - Google Patents
For the amplification of androgen receptor gene full coding region abrupt climatic change and sequencing primer and test kit thereof Download PDFInfo
- Publication number
- CN103993084B CN103993084B CN201410223073.7A CN201410223073A CN103993084B CN 103993084 B CN103993084 B CN 103993084B CN 201410223073 A CN201410223073 A CN 201410223073A CN 103993084 B CN103993084 B CN 103993084B
- Authority
- CN
- China
- Prior art keywords
- exon
- seqidno
- nmolseqidno
- sequencing primer
- amplification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000012163 sequencing technique Methods 0.000 title claims abstract description 83
- 108010080146 androgen receptors Proteins 0.000 title claims abstract description 79
- 230000003321 amplification Effects 0.000 title claims abstract description 44
- 238000003199 nucleic acid amplification method Methods 0.000 title claims abstract description 44
- 108091026890 Coding region Proteins 0.000 title claims abstract description 13
- 238000012360 testing method Methods 0.000 title abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 54
- 108700024394 Exon Proteins 0.000 claims abstract description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 40
- 238000002156 mixing Methods 0.000 claims description 38
- 239000000203 mixture Substances 0.000 claims description 35
- 239000007864 aqueous solution Substances 0.000 claims description 33
- 238000003752 polymerase chain reaction Methods 0.000 claims description 19
- 238000013016 damping Methods 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 239000000975 dye Substances 0.000 claims description 3
- 238000013461 design Methods 0.000 claims description 2
- 101150029129 AR gene Proteins 0.000 claims 2
- 238000001514 detection method Methods 0.000 abstract description 7
- 230000001548 androgenic effect Effects 0.000 abstract description 5
- 102000005962 receptors Human genes 0.000 abstract description 4
- 108020003175 receptors Proteins 0.000 abstract description 4
- 238000012408 PCR amplification Methods 0.000 abstract description 3
- 238000001962 electrophoresis Methods 0.000 abstract description 2
- 239000007850 fluorescent dye Substances 0.000 abstract description 2
- 102100032187 Androgen receptor Human genes 0.000 description 64
- 108020004414 DNA Proteins 0.000 description 27
- 206010056292 Androgen-Insensitivity Syndrome Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 206010064571 Gene mutation Diseases 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 108010007577 Exodeoxyribonuclease I Proteins 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 208000022823 partial androgen insensitivity syndrome Diseases 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000001712 DNA sequencing Methods 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 208000012482 complete androgen insensitivity syndrome Diseases 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010070597 Disorder of sex development Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000008779 Exonuclease 1 Human genes 0.000 description 1
- 208000028782 Hereditary disease Diseases 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 206010037124 Pseudohermaphroditism male Diseases 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 210000001766 X chromosome Anatomy 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 101150036080 at gene Proteins 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 108020001756 ligand binding domains Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- -1 methane amide Chemical class 0.000 description 1
- 102000006255 nuclear receptors Human genes 0.000 description 1
- 108020004017 nuclear receptors Proteins 0.000 description 1
- 238000012803 optimization experiment Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000012882 sequential analysis Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of amplification for androgen receptor gene full coding region abrupt climatic change and sequencing primer and test kit thereof.Comprise pcr amplification reaction solution A in test kit, wrap by the reaction tubes of primer, and order-checking primer E1-A, E1-B, E1-C, E1-D, E2, E3, E4, E5, E6, E7, E8.The present invention can disposablely increase to all 8 exons of human androgenic receptor under the same reaction conditions, then is checked order by sequencing primer.Be with fluorescence dye in PCR reaction system, directly can understand amplification, the inconvenience avoiding electrophoresis to bring and pollution by fluorescent value change.Primer direct coated, in reaction tubes, avoids primer to configure difficulty.Can detect CAG multiplicity in First Exon, the present invention can be used for the detection to clinical samples, can provide more bioinformation.
Description
Technical field
The present invention relates to the molecular biology method based on polymerase chain reaction (PCR) and DNA sequencing technology, particularly relate to a kind of amplification for androgen receptor (AR) gene full coding region abrupt climatic change and sequencing primer and test kit thereof.
Background technology
Androgen-insensitivity syndrome (AIS) is that a class causes the stealthy inherited disease of the X chromosome of sexual abnormality (DSD), pathogenesis and AR transgenation closely related.Patient's caryogram is 46, XY, the androgen receptor defect on male sex hormone target organ and cause all or part of forfeiture of androgenic normal effect.According to clinical manifestation, two kinds of hypotypes can be divided into: perfect form androgen-insensitivity syndrome (CAIS) and reifenstein syndrome (PAIS).
The androgen receptor gene of encoding androgen receptor albumen is positioned at Xq11-12, androgen receptor gene overall length 75 ~ 90kb, comprises 7 introns and 8 exons.AR belongs to nuclear receptor superfamily member, be made up of 910 ~ 919 amino acid, molecular weight is 110 ~ 114kDa, is made up of three, the ligand binding domain functional domain of the transcriptional activation domain of the 1st exons coding, the DNA land of the 2nd and the 3rd exons coding and the 4-8 exons coding.At gene level, the Androgen receptor gene mutation found roughly has following several: 1. point mutation causes amino acid to replace or termination codon occurs in advance or normal shearing site suddenlys change 2. nucleotide deletion or insertion causes phase shift mutation 3. CAG tumor-necrosis factor glycoproteins extension or shortening etc. in exons 1.CAIS, PAIS, MAIS that the AR transgenation ending in April, 2013 renewal causes and cancer (comprising prostate cancer, liver cancer, mammary cancer) have kind more than 1000.Androgen receptor gene mutation order-checking detects, can be diagnosis androgen-insensitivity syndrome and important diagnosis basis is provided, contact between the pathogenesis of the research structure and function of androgen receptor, androgen-insensitivity syndrome is provided to the basis of technical Analysis, there is more important clinical meaning.
At present, also untappedly go out to detect comprehensively, result Androgen receptor gene mutation order-checking accurately detection kit, for clinical diagnosis.The present invention is based on polymerase chain reaction (PCR) and DNA sequencing technology, a set of desirable primer increased and checked order in the full coding region of androgen receptor gene is obtained by design, screening, reach the object whether complete detection androgen receptor gene undergos mutation, carry out gene type accurately.
Summary of the invention
The object of the invention is to overcome in existing molecular diagnostic techniques detect androgen receptor mutation type many, detect incomplete defect, there is provided a set of optimization primer for pcr amplification and order-checking, disposablely under the same conditions can carry out 11 PCR, smoothly the full coding region of amplification and order-checking androgen receptor gene.
The present invention's second object is to provide the specific PCR response procedures that a kind of this primer supporting carries out androgen receptor gene full coding region abrupt climatic change, reaches the object of rapid amplifying.
The present invention's the 3rd object is to provide a kind ofly carries out to clinical samples the fluorescent PCR amplification kit that androgen receptor carries out sequential analysis.
Technical scheme of the present invention is summarized as follows:
For amplification and the sequencing primer of androgen receptor gene full coding region abrupt climatic change, the amplification and the sequencing primer that comprise First Exon are SEQIDNO.1-SEQIDNO.9, the amplification of Second Exon and sequencing primer are SEQIDNO.10 and SEQIDNO.11, the amplification of the 3rd exon and sequencing primer are SEQIDNO.12 and SEQIDNO.13, the amplification of the 4th exon and sequencing primer are SEQIDNO.14-SEQIDNO.16, the amplification of the 5th exon and sequencing primer are SEQIDNO.17 and SEQIDNO.18, the amplification of the 6th exon and sequencing primer are SEQIDNO.19 and SEQIDNO.20, the amplification of the 7th exon and sequencing primer are SEQIDNO.21-SEQIDNO.23, the amplification of the 8th exon and sequencing primer are SEQIDNO.24 and SEQIDNO.25.
The PCR reaction of supporting amplification Androgen receptor Exon is after 95 DEG C of denaturation 3min, 94 DEG C of sex change 15s, 60 DEG C of annealing 15s, and 72 DEG C extend 35s, carry out 35 circulations, be then kept at 25 DEG C; Timely taking-up is checked order.
A kind of for the amplification of androgen receptor gene full coding region abrupt climatic change and sequencing kit:
Reagent A: be made up of 2mL damping fluid, comprise 2 × SYBR GreenI dyestuff, 0.2mMdNTPs(comprises dATP, dCTP, dGTP, dTTP), 80mMTris-HCl, 80mMKCl, 40mM (NH4) 2SO4,6mMMgSO4,100UTaqDNA polysaccharase;
Reagent E 1-A: by the sequencing primer 30 μ L aqueous solution for AR First Exon E1-A, comprise 4 μMs of SEQIDNO.1;
Reagent E 1-B: by the sequencing primer 30 μ L aqueous solution for AR First Exon E1-B, comprise 4 μMs of SEQIDNO.3;
Reagent E 1-C: by the sequencing primer 30 μ L aqueous solution for AR First Exon E1-C, comprise 4 μMs of SEQIDNO.7;
Reagent E 1-D: by the sequencing primer 30 μ L aqueous solution for AR First Exon E1-D, comprise 4 μMs of SEQIDNO.8;
Reagent E 2: by the sequencing primer 30 μ L aqueous solution for AR Second Exon E2, comprise 4 μMs of SEQIDNO.11;
Reagent E 3: by the sequencing primer 30 μ L aqueous solution for AR the 3rd exon E3, comprise 4 μMs of SEQIDNO.12;
Reagent E 4: by the sequencing primer 30 μ L aqueous solution for AR the 4th exon E4, comprise 4 μMs of SEQIDNO.16;
Reagent E 5: by the sequencing primer 30 μ L aqueous solution for AR the 5th exon E5, comprise 4 μMs of SEQIDNO.18;
Reagent E 6: by the sequencing primer 30 μ L aqueous solution for AR the 5th exon E6, comprise 4 μMs of SEQIDNO.19;
Reagent E 7: by the sequencing primer 30 μ L aqueous solution for AR the 5th exon E7, comprise 4 μMs of SEQIDNO.23;
Reagent E 8: by the sequencing primer 30 μ L aqueous solution for AR the 5th exon E8, comprise 4 μMs of SEQIDNO.24;
Bag is by the PCR reaction tubes of primer:
A reaction tubes: containing the amplimer mixing composition for AR First Exon E1-A, comprise 1.5 × 10
-2nmolSEQIDNO.1 and 1.5 × 10
-2nmolSEQIDNO.2;
No. two reaction tubess: containing the amplimer mixing composition for AR First Exon E1-B, comprise 1.5 × 10
-2nmolSEQIDNO.3 and 1.5 × 10
-2nmolSEQIDNO.4;
No. three reaction tubess: containing the amplimer mixing composition for AR First Exon E1-C, comprise 1.5 × 10
-2nmolSEQIDNO.5 and 1.5 × 10
-2nmolSEQIDNO.6;
No. four reaction tubess: containing the amplimer mixing composition for AR First Exon E1-D, comprise 1.5 × 10
-2nmolSEQIDNO.8 and 1.5 × 10
-2nmolSEQIDNO.9;
No. five reaction tubess: containing the amplimer mixing composition for AR Second Exon E2, comprise 1.5 × 10
-2nmolSEQIDNO.10 and 1.5 × 10
-2nmolSEQIDNO.11;
No. six reaction tubess: containing the amplimer mixing composition for AR the 3rd exon E3, comprise 1.5 × 10
-2nmolSEQIDNO.12 and 1.5 × 10
-2nmolSEQIDNO.13;
No. seven reaction tubess: containing the amplimer mixing composition for AR the 3rd exon E4, comprise 1.5 × 10
-2nmolSEQIDNO.14 and 1.5 × 10
-2nmolSEQIDNO.15;
No. eight reaction tubess: containing the amplimer mixing composition for AR the 3rd exon E5, comprise 1.5 × 10
-2nmolSEQIDNO.17 and 1.5 × 10
-2nmolSEQIDNO.18;
No. nine reaction tubess: containing the amplimer mixing composition for AR the 3rd exon E6, comprise 1.5 × 10
-2nmolSEQIDNO.19 and 1.5 × 10
-2nmolSEQIDNO.20;
No. ten reaction tubess: containing the amplimer mixing composition for AR the 3rd exon E7, comprise 1.5 × 10
-2nmolSEQIDNO.21 and 1.5 × 10
-2nmolSEQIDNO.22;
Ride on Bus No. 11 reaction tubes: containing the amplimer mixing composition for AR the 3rd exon E8, comprise 1.5 × 10
-2nmolSEQIDNO.24 and 1.5 × 10
-2nmolSEQIDNO.25.
Advantage of the present invention:
A kind of amplification for androgen receptor gene full coding region abrupt climatic change and sequencing primer and test kit thereof are provided.Its advantage is: 1) provide and a set ofly carry out the primer of fast PCR and the sequencing primer of optimization, and the sequence of all 8 exons of all androgen receptor genes of disposable amplification is used for follow-up order-checking; 2) be with fluorescence dye in reaction system, directly can observe amplification by quantitative fluorescent PCR, the inconvenience avoiding electrophoresis to bring and pollution; 3) the CAG tumor-necrosis factor glycoproteins in androgen receptor First Exon can be found, more bioinformation can be provided; 4) primer direct coated is in reaction tubes, avoids primer to configure difficulty.By optimization experiment reaction system and reaction conditions, form simple, quick, sensitive, special detection kit, can be used for the detection to clinical samples, can man power and material be reduced, more experiment information is provided.
Accompanying drawing explanation
Fig. 1 is the fluorescent value of human androgenic receptor fragment amplification.
Fig. 2 is human androgenic receptor sequencing fragment result.
Embodiment
In following embodiment, method therefor is ordinary method if no special instructions.
Amplification of the present invention and sequencing primer nucleotides sequence are classified as:
Embodiment 1
A set of Auele Specific Primer increasing for androgen receptor and check order, the amplification and the sequencing primer that comprise First Exon are SEQIDNO.1-SEQIDNO.9, the amplification of Second Exon and sequencing primer are SEQIDNO.10 and SEQIDNO.11, the amplification of the 3rd exon and sequencing primer are SEQIDNO.12 and SEQIDNO.13, the amplification of the 4th exon and sequencing primer are SEQIDNO.14-SEQIDNO.16, the amplification of the 5th exon and sequencing primer are SEQIDNO.17 and SEQIDNO.18, the amplification of the 6th exon and sequencing primer are SEQIDNO.19 and SEQIDNO.20, the amplification of the 7th exon and sequencing primer are SEQIDNO.21-SEQIDNO.23, the amplification of the 8th exon and sequencing primer are SEQIDNO.24 and SEQIDNO.25.
Embodiment 2
For the test kit increasing to androgen receptor and check order, be made up of following reagent:
Reagent A: be made up of 2mL damping fluid, comprise 2 × SYBR GreenI dyestuff, 0.2mMdNTPs(comprises dATP, dCTP, dGTP, dTTP), 80mMTris-HCl, 80mMKCl, 40mM (NH4) 2SO4,6mMMgSO4,100UTaqDNA polysaccharase;
Reagent E 1-A: by the sequencing primer 30 μ L aqueous solution for AR First Exon E1-A, comprise 4 μMs of SEQIDNO.1;
Reagent E 1-B: by the sequencing primer 30 μ L aqueous solution for AR First Exon E1-B, comprise 4 μMs of SEQIDNO.3;
Reagent E 1-C: by the sequencing primer 30 μ L aqueous solution for AR First Exon E1-C, comprise 4 μMs of SEQIDNO.7;
Reagent E 1-D: by the sequencing primer 30 μ L aqueous solution for AR First Exon E1-D, comprise 4 μMs of SEQIDNO.8;
Reagent E 2: by the sequencing primer 30 μ L aqueous solution for AR Second Exon E2, comprise 4 μMs of SEQIDNO.11;
Reagent E 3: by the sequencing primer 30 μ L aqueous solution for AR the 3rd exon E3, comprise 4 μMs of SEQIDNO.12;
Reagent E 4: by the sequencing primer 30 μ L aqueous solution for AR the 4th exon E4, comprise 4 μMs of SEQIDNO.16;
Reagent E 5: by the sequencing primer 30 μ L aqueous solution for AR the 5th exon E5, comprise 4 μMs of SEQIDNO.18;
Reagent E 6: by the sequencing primer 30 μ L aqueous solution for AR the 5th exon E6, comprise 4 μMs of SEQIDNO.19;
Reagent E 7: by the sequencing primer 30 μ L aqueous solution for AR the 5th exon E7, comprise 4 μMs of SEQIDNO.23;
Reagent E 8: by the sequencing primer 30 μ L aqueous solution for AR the 5th exon E8, comprise 4 μMs of SEQIDNO.24;
Bag is by the PCR reaction tubes of primer:
A reaction tubes: containing the amplimer mixing composition for AR First Exon E1-A, comprise 1.5 × 10
-2nmolSEQIDNO.1 and 1.5 × 10
-2nmolSEQIDNO.2;
No. two reaction tubess: containing the amplimer mixing composition for AR First Exon E1-B, comprise 1.5 × 10
-2nmolSEQIDNO.3 and 1.5 × 10
-2nmolSEQIDNO.4;
No. three reaction tubess: containing the amplimer mixing composition for AR First Exon E1-C, comprise 1.5 × 10
-2nmolSEQIDNO.5 and 1.5 × 10
-2nmolSEQIDNO.6;
No. four reaction tubess: containing the amplimer mixing composition for AR First Exon E1-D, comprise 1.5 × 10
-2nmolSEQIDNO.8 and 1.5 × 10
-2nmolSEQIDNO.9;
No. five reaction tubess: containing the amplimer mixing composition for AR Second Exon E2, comprise 1.5 × 10
-2nmolSEQIDNO.10 and 1.5 × 10
-2nmolSEQIDNO.11;
No. six reaction tubess: containing the amplimer mixing composition for AR the 3rd exon E3, comprise 1.5 × 10
-2nmolSEQIDNO.12 and 1.5 × 10
-2nmolSEQIDNO.13;
No. seven reaction tubess: containing the amplimer mixing composition for AR the 3rd exon E4, comprise 1.5 × 10
-2nmolSEQIDNO.14 and 1.5 × 10
-2nmolSEQIDNO.15;
No. eight reaction tubess: containing the amplimer mixing composition for AR the 3rd exon E5, comprise 1.5 × 10
-2nmolSEQIDNO.17 and 1.5 × 10
-2nmolSEQIDNO.18;
No. nine reaction tubess: containing the amplimer mixing composition for AR the 3rd exon E6, comprise 1.5 × 10
-2nmolSEQIDNO.19 and 1.5 × 10
-2nmolSEQIDNO.20;
No. ten reaction tubess: containing the amplimer mixing composition for AR the 3rd exon E7, comprise 1.5 × 10
-2nmolSEQIDNO.21 and 1.5 × 10
-2nmolSEQIDNO.22;
Ride on Bus No. 11 reaction tubes: containing the amplimer mixing composition for AR the 3rd exon E8, comprise 1.5 × 10
-2nmolSEQIDNO.24 and 1.5 × 10
-2nmolSEQIDNO.25.
Embodiment 3
Carry out real-time fluorescence quantitative PCR (real-timeFQPCR) with test kit of the present invention to increase all exons of androgen receptor.First, sample number empirically calculates the requirement of each reagent, and experimental procedure is as follows:
1. amplification reaction solution configuration: configure reaction solution (1 is detected sample) in order, add water 120 μ L, reagent A 150 μ L, DNA sample 30 μ L, totally 300 μ L; Mixing.
2. each pipe is sequentially added into the amplification reaction solution of 25 μ L, builds lid.
3. the PCR program empirically designed increases: be after 95 DEG C of denaturation 3min, 94 DEG C of sex change 1min, 60 DEG C of annealing 1mins, and 72 DEG C extend 35s, and extended peroid obtains fluorescent value, carries out 35 circulations, is finally kept at 25 DEG C; Timely taking-up is checked order.
4. fluorescent value is 22-28 circulation take-off, and specific amplification is thought in the take-off simultaneously of each group, sees Fig. 1.
Embodiment 4
The primer supporting with test kit of the present invention checks order:
1.PCR product purification (ExoI/SAP method):
1.1 preparation purification system: exonuclease 1(ExoI) 6 μ L+ shrimp solution enzyme (SAP) 12 μ L+ water 6 μ L, totally 24 μ L, mixing.
The 1.2 purification system 2 μ L getting preparation mix (11) with each amplified production 8 μ L totally, add in another blank Sptting plate.
Sptting plate is placed on more than PCR instrument by 1.3,37 DEG C of 30min, 80 DEG C of 20min, can preserve about 1 week in 4 DEG C of refrigerators.
2. sequencing reaction:
In 2.110 μ LPCR purified products, every hole adds 20 μ L water, fully after mixing, centrifugal.
2.2 preparation sequencing reaction systems: get 4.8 μ LBDTReadyReactionPremix (2.5 ×) and add 21.6 μ LBDT damping fluids (5 ×) and add 69.6 μ LDeionisedwater and mix.Get the above-mentioned mixed solution of 8 μ L each 1 μ L fully mixes with E1-A, E1-B, E1-C, E1-D, E2, E3, E4, E5, E6, E7, E8 respectively at every turn, centrifugal fast.
2.3 every hole PCR primer diluents get 1 μ L to (11 hole) in reacting hole, and every hole adds 9 μ L sequencing reaction mixed solutions, mixing, centrifugal fast.
Sptting plate is placed in PCR instrument by 2.4, and PCR sealing load pad is put at Sptting plate top, to prevent liquid evaporation, shuts PCR instrument, runs sequencing reaction: after 96 DEG C of 10s, carrying out 25 circulations is 96 DEG C of 10s, 50 DEG C of 10s, 60 DEG C of 2min, finally preserves 15 DEG C and takes out.
3. sequencing reaction product purification:
1 μ LEDTA, 1 μ LNaAc and 25 μ L dehydrated alcohols are added, fully concussion mixing 30s in 3.1 sequencing reaction hole, every holes.Room temperature places the centrifugal 30min. of 15min, 3000rpm
3.2 are inverted Sptting plate, adjusting rotary speed, the centrifugal 1min of 500rpm
50 μ L70% ethanol are added, the centrifugal 10min of 3000rpm in 3.3 every hole sequencing reaction products.
3.4 are inverted Sptting plate, the centrifugal 1min of 500rpm.
3.5 room temperature lucifuges leave standstill 30min, fully ethanol in volatilization plate.
Add methane amide 10 μ L, shrouding in 3.6 every holes, be placed on more than PCR 95 DEG C of 2min, put into rapidly-20 DEG C of refrigerator cooling 3-5min.
4. sequenator reads plate detection: use ABI3500 sequenator to detect sequencing result.The sequencing result software that makes to check order accordingly carries out data analysis, sees Fig. 2.
Embodiment 5
Sequencing result and androgen receptor standard sequence are compared:
1. sequencing result splices;
2. the order-checking of androgen receptor standard and sequencing result Input Software are compared;
3. check emergent properties and analyze the repetition rate of First Exon CAG.
Sequence table
<110> The First Affiliated Hospital of Wenzhou Medical University
The test kit of <120> human androgenic receptor detection in Gene Mutation
<160>25
<170>PatentInVersion2.1
<210>1
<211>19
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(19)
<400>1
gcagcgactaccgcatcat19
<210>2
<211>18
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(18)
<400>2
acaacgtggatggggcag18
<210>3
<211>20
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(20)
<400>3
gagagaggttgcgtcccaga20
<210>4
<211>22
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(22)
<400>4
cctttggtgtaacctcccttga22
<210>5
<211>21
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(21)
<400>5
tgtaaggcagtgtcggtgtcc21
<210>6
<211>21
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(21)
<400>6
ccatacaactggccttcttcg21
<210>7
<211>19
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(19)
<400>7
gaggcgttggagcatctga19
<210>8
<211>20
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(20)
<400>8
tggagaacccgctggactac20
<210>9
<211>21
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(21)
<400>9
gcacgcagcagaaattaggag21
<210>10
<211>25
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(25)
<400>10
agcttcacactaactaacttgagca25
<210>11
<211>23
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(23)
<400>11
gcaagtacaaaaatttgcttcct23
<210>12
<211>25
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(25)
<400>12
tgaataatagtcatttatgcctgca25
<210>13
<211>22
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(22)
<400>13
ctatgaaagggtcagcctgtgt22
<210>14
<211>23
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(23)
<400>14
gtttagagtctgtgaccagggag23
<210>15
<211>22
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(22)
<400>15
ctgagttaatgggcagaaaagc22
<210>16
<211>23
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(23)
<400>16
gggagaatggtgattttcttagc23
<210>17
<211>24
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(24)
<400>17
tcaccatatagtttgtgcttttcc24
<210>18
<211>24
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(24)
<400>18
acaactgcagatcaaatgagctaa24
<210>19
<211>21
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(21)
<400>19
gctcttcttggaaaacctggc21
<210>20
<211>24
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(24)
<400>20
gctggcttttccctaataatgttt24
<210>21
<211>24
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(24)
<400>21
agcacacagacttcaactaacagg24
<210>22
<211>22
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(22)
<400>22
ttcttcctggaccacactcaaa22
<210>23
<211>22
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(22)
<400>23
aagccaagtagatggttccctg22
<210>24
<211>22
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(22)
<400>24
aggaaacaaaaggctgaaagac22
<210>25
<211>24
<212>DNA
<213> artificial sequence
<220>
<221>prim_bind
<222>(1)...(24)
<400>25
agtgcagagttataacaggcagaa24
Claims (2)
1. a set of amplification for androgen receptor gene full coding region abrupt climatic change and sequencing primer, it is characterized in that on the basis of optimize PCR design of primers, disposablely under the same conditions can carry out 11 polymerase chain reactions, complete the amplification of AR gene complete penetrance, and carry out all 8 exons order-checkings in the full coding region of AR gene by sequencing primer, the amplification and the sequencing primer that comprise First Exon are SEQIDNO.1-SEQIDNO.9, the amplification of Second Exon and sequencing primer are SEQIDNO.10 and SEQIDNO.11, the amplification of the 3rd exon and sequencing primer are SEQIDNO.12 and SEQIDNO.13, the amplification of the 4th exon and sequencing primer are SEQIDNO.14-SEQIDNO.16, the amplification of the 5th exon and sequencing primer are SEQIDNO.17 and SEQIDNO.18, the amplification of the 6th exon and sequencing primer are SEQIDNO.19 and SEQIDNO.20, the amplification of the 7th exon and sequencing primer are SEQIDNO.21-SEQIDNO.23, the amplification of the 8th exon and sequencing primer are SEQIDNO.24 and SEQIDNO.25.
2., for the amplification of androgen receptor gene full coding region abrupt climatic change and a sequencing kit, be made up of following reagent:
Reagent A: be made up of 2mL damping fluid, comprises 2 × SYBR GreenI dyestuff, 0.2mMdNTPs, 80mMTris-HCl, 80mMKCl, 40mM (NH
4)
2sO
4, 6mMMgSO4,100UTaqDNA polysaccharase;
Reagent E 1-A: by the sequencing primer 30 μ L aqueous solution for AR First Exon E1-A, comprise 4 μMs of SEQIDNO.1;
Reagent E 1-B: by the sequencing primer 30 μ L aqueous solution for AR First Exon E1-B, comprise 4 μMs of SEQIDNO.3;
Reagent E 1-C: by the sequencing primer 30 μ L aqueous solution for AR First Exon E1-C, comprise 4 μMs of SEQIDNO.7;
Reagent E 1-D: by the sequencing primer 30 μ L aqueous solution for AR First Exon E1-D, comprise 4 μMs of SEQIDNO.8;
Reagent E 2: by the sequencing primer 30 μ L aqueous solution for AR Second Exon E2, comprise 4 μMs of SEQIDNO.11;
Reagent E 3: by the sequencing primer 30 μ L aqueous solution for AR the 3rd exon E3, comprise 4 μMs of SEQIDNO.12;
Reagent E 4: by the sequencing primer 30 μ L aqueous solution for AR the 4th exon E4, comprise 4 μMs of SEQIDNO.16;
Reagent E 5: by the sequencing primer 30 μ L aqueous solution for AR the 5th exon E5, comprise 4 μMs of SEQIDNO.18;
Reagent E 6: by the sequencing primer 30 μ L aqueous solution for AR the 5th exon E6, comprise 4 μMs of SEQIDNO.19;
Reagent E 7: by the sequencing primer 30 μ L aqueous solution for AR the 5th exon E7, comprise 4 μMs of SEQIDNO.23;
Reagent E 8: by the sequencing primer 30 μ L aqueous solution for AR the 5th exon E8, comprise 4 μMs of SEQIDNO.24;
Bag is by the PCR reaction tubes of primer:
A reaction tubes: containing the amplimer mixing composition for AR First Exon E1-A, comprise 1.5 × 10
-2nmolSEQIDNO.1 and 1.5 × 10
-2nmolSEQIDNO.2;
No. two reaction tubess: containing the amplimer mixing composition for AR First Exon E1-B, comprise 1.5 × 10
-2nmolSEQIDNO.3 and 1.5 × 10
-2nmolSEQIDNO.4;
No. three reaction tubess: containing the amplimer mixing composition for AR First Exon E1-C, comprise 1.5 × 10
-2nmolSEQIDNO.5 and 1.5 × 10
-2nmolSEQIDNO.6;
No. four reaction tubess: containing the amplimer mixing composition for AR First Exon E1-D, comprise 1.5 × 10
-2nmolSEQIDNO.8 and 1.5 × 10
-2nmolSEQIDNO.9;
No. five reaction tubess: containing the amplimer mixing composition for AR Second Exon E2, comprise 1.5 × 10
-2nmolSEQIDNO.10 and 1.5 × 10
-2nmolSEQIDNO.11;
No. six reaction tubess: containing the amplimer mixing composition for AR the 3rd exon E3, comprise 1.5 × 10
-2nmolSEQIDNO.12 and 1.5 × 10
-2nmolSEQIDNO.13;
No. seven reaction tubess: containing the amplimer mixing composition for AR the 3rd exon E4, comprise 1.5 × 10
-2nmolSEQIDNO.14 and 1.5 × 10
-2nmolSEQIDNO.15;
No. eight reaction tubess: containing the amplimer mixing composition for AR the 3rd exon E5, comprise 1.5 × 10
-2nmolSEQIDNO.17 and 1.5 × 10
-2nmolSEQIDNO.18;
No. nine reaction tubess: containing the amplimer mixing composition for AR the 3rd exon E6, comprise 1.5 × 10
-2nmolSEQIDNO.19 and 1.5 × 10
-2nmolSEQIDNO.20;
No. ten reaction tubess: containing the amplimer mixing composition for AR the 3rd exon E7, comprise 1.5 × 10
-2nmolSEQIDNO.21 and 1.5 × 10
-2nmolSEQIDNO.22;
Ride on Bus No. 11 reaction tubes: containing the amplimer mixing composition for AR the 3rd exon E8, comprise 1.5 × 10
-2nmolSEQIDNO.24 and 1.5 × 10
-2nmolSEQIDNO.25.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410223073.7A CN103993084B (en) | 2014-05-26 | 2014-05-26 | For the amplification of androgen receptor gene full coding region abrupt climatic change and sequencing primer and test kit thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410223073.7A CN103993084B (en) | 2014-05-26 | 2014-05-26 | For the amplification of androgen receptor gene full coding region abrupt climatic change and sequencing primer and test kit thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103993084A CN103993084A (en) | 2014-08-20 |
CN103993084B true CN103993084B (en) | 2015-12-09 |
Family
ID=51307412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410223073.7A Expired - Fee Related CN103993084B (en) | 2014-05-26 | 2014-05-26 | For the amplification of androgen receptor gene full coding region abrupt climatic change and sequencing primer and test kit thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103993084B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108018342A (en) * | 2017-12-04 | 2018-05-11 | 合肥艾迪康临床检验所有限公司 | Detect the primer and method of AR gene mutations |
CN108060232A (en) * | 2017-12-13 | 2018-05-22 | 安徽师范大学 | For expanding tortoise androgen receptor(AR)The RT-qPCR primers and method of gene |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102439454A (en) * | 2009-02-11 | 2012-05-02 | 卡里斯Mpi公司 | Molecular profiling of tumors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2283152A1 (en) * | 2008-04-04 | 2011-02-16 | Goodgene Inc. | New skin sampling kit which stores nucleic acids in stable status, genetic test methods by using the kit and their practical application |
CN101905788A (en) * | 2010-07-14 | 2010-12-08 | 中冶赛迪工程技术股份有限公司 | Self-locking bottom opening trough |
-
2014
- 2014-05-26 CN CN201410223073.7A patent/CN103993084B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102439454A (en) * | 2009-02-11 | 2012-05-02 | 卡里斯Mpi公司 | Molecular profiling of tumors |
Non-Patent Citations (1)
Title |
---|
男性不育的遗传学研究及在ICSI中的意义;李亚丽等;《中国优生与遗传杂志》;20061231;第14卷(第5期);正文第19页右栏第9-15行 * |
Also Published As
Publication number | Publication date |
---|---|
CN103993084A (en) | 2014-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Old et al. | Fetal DNA analysis | |
Muro et al. | Determination of ABO genotypes by real-time PCR using allele-specific primers | |
CN105296619A (en) | Kit for SNP typing of obesity-prone genes of Chinese population and using method of kit | |
Habibi et al. | The effects of vitrification on gene expression in mature mouse oocytes by nested quantitative PCR | |
CN101768642B (en) | Molecular marking method for pig litter size | |
Paul et al. | DNA extraction from plant leaves using a microneedle patch | |
CN103757091A (en) | Rapid gene detection kit and rapid gene detection method for sudden cardiac death | |
CN103993084B (en) | For the amplification of androgen receptor gene full coding region abrupt climatic change and sequencing primer and test kit thereof | |
Zhang et al. | PCR multiplexing based on a single fluorescent channel using dynamic melting curve analysis | |
CN101805790A (en) | Method for simultaneously detecting polymorphism of 32 SNP loci on 24 sports-related genes | |
US20130115601A1 (en) | Tissue typing assays and kits | |
CN104830852A (en) | Multiplex real-time fluorescent PCR (polymerase chain reaction) method for detecting HLA-B*15:02 alleles | |
Jacobsen et al. | Profiling microRNAs by real-time PCR | |
CN101921860A (en) | Multicolor fluorescence composite detection method and kit of 44 SNPs (Single Nucleotide Polymorphism) loci | |
CN109486964B (en) | Microsatellite rapid detection method for individual identification and paternity test of donkeys | |
CN106978501A (en) | A kind of method of the direct real-time fluorescence PCR of whole blood | |
CN105986044A (en) | Universal method for quickly detecting nucleic acid of avian influenza virus | |
CN104611425B (en) | A kind of SNP marker related to china holstein cowses S. aureus L-forms Mastitis resistance and its application | |
CN104293968B (en) | One group for detecting pleomorphism site and the detection kit of non-syndromic cleft lip with cleft palate genetic predisposition | |
CN107988334B (en) | Method for SNP typing by direct PCR of oral swab | |
CN105274220A (en) | CYP4F2*3 detection primer and detection system thereof | |
CN104561285A (en) | Amplification and sequencing primer and reagent kit for single nucleotide polymorphism detection of microRNA-146a (micro ribonucleic acid-146a) gene and in prozone | |
Li et al. | Typing of 67 SNP loci on X chromosome by PCR and MALDI-TOF MS | |
CN104789673B (en) | Applications of the rs1800818 in heating companion's thrombocytopenic syndromes that new bunyavirus causes are detected | |
Liu et al. | Direct genotyping from whole blood using alkaline polyethylene glycol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151209 |